4//SEC Filing
Third Rock Ventures II, L.P. 4
Accession 0000899243-20-031066
CIK 0001640455other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 8:26 PM ET
Size
16.1 KB
Accession
0000899243-20-031066
Insider Transaction Report
Form 4
Third Rock Ventures II, L.P.
10% Owner
Transactions
- Other
Common Stock
2020-11-11−1,000,000→ 9,230,349 total
Holdings
- 53,599
Common Stock
- 53,597
Common Stock
- 53,592
Common Stock
Third Rock Ventures GP II, L.P.
10% Owner
Transactions
- Other
Common Stock
2020-11-11−1,000,000→ 9,230,349 total
Holdings
- 53,592
Common Stock
- 53,597
Common Stock
- 53,599
Common Stock
TRV GP II, LLC
10% Owner
Transactions
- Other
Common Stock
2020-11-11−1,000,000→ 9,230,349 total
Holdings
- 53,592
Common Stock
- 53,597
Common Stock
- 53,599
Common Stock
LEVIN MARK J
10% Owner
Transactions
- Other
Common Stock
2020-11-11−1,000,000→ 9,230,349 total
Holdings
- 53,592
Common Stock
- 53,597
Common Stock
- 53,599
Common Stock
STARR KEVIN P
10% Owner
Transactions
- Other
Common Stock
2020-11-11−1,000,000→ 9,230,349 total
Holdings
- 53,597
Common Stock
- 53,592
Common Stock
- 53,599
Common Stock
TEPPER ROBERT I
Director10% Owner
Transactions
- Other
Common Stock
2020-11-11−1,000,000→ 9,230,349 total
Holdings
- 53,597
Common Stock
- 53,592
Common Stock
- 53,599
Common Stock
Footnotes (5)
- [F1]On November 11, 2020, Third Rock Ventures II, L.P. ("TRV II") distributed for no consideration, 1,000,000 shares of Common Stock of the Issuer (the "Shares") to its limited partners and to Third Rock Ventures GP II, L.P. ("TRV GP II"), the general partner of TRV II, representing each such partner's pro rata interest in such Shares. On the same date, TRV GP II distributed, for no consideration, the Shares it received in the distribution by TRV II to its partners, representing each such partner's pro rata interest in such Shares. All of the aforementioned distributions were made in accordance with the exemptions afforded by Rules 16a-13 and 16a-9 of the Securities Exchange Act of 1934, as amended.
- [F2]These shares are directly held by TRV II. The general partner of TRV II is TRV GP II. The general partner of TRV GP II is TRV GP II, LLC ("TRV GP II LLC"). The individual managers of TRV GP II LLC are Mark Levin ("Levin"), Kevin Starr ("Starr") and Dr. Robert Tepper ("Tepper"). Each of TRV GP II, TRV GP II LLC, Levin, Starr and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
- [F3]The shares are directly held by Levin. Includes Shares received in the distributions described in footnote (1) above.
- [F4]The shares are directly held by Starr. Includes Shares received in the distributions described in footnote (1) above.
- [F5]The shares are directly held by Tepper. Includes Shares received in the distributions described in footnote (1) above.
Documents
Issuer
Jounce Therapeutics, Inc.
CIK 0001640455
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001488495
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 8:26 PM ET
- Size
- 16.1 KB